Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2103 of 6351
-
New combo aims to boost remission in leukemia
Disease control OngoingThis is a pilot phase 2 study investigating the safety and efficacy of ibrutinib combined with short-course fludarabine in previously untreated CLL patients. Ibrutinib will be given daily until disease progression or intolerable side effects occur. Fludarabine will be given in cy…
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for ulcerative colitis: Long-Term safety of oral drug tested
Disease control CompletedThe purpose of this study is to evaluate the long-term safety and efficacy of RPC1063 in participants with moderately to severely active ulcerative colitis. Only those participants who have previously participated in a trial of RPC1063, being either RPC01-3101 or completed at lea…
Phase 3 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Heat zaps seizures: new hope for kids with Drug-Resistant epilepsy
Symptom relief CompletedWhen focal epilepsies become drug-resistant, it could be eligible for cortical surgical resection. Therefore, an invasive EEG monitoring with depth electrodes is often needed during presurgical evaluation. Some of these children can have access to thermocoagulation inside the ict…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Could diabetes be silently damaging your hearing?
Diagnosis CompletedDiabetes is now the most common chronic disease, affecting nearly 6% of the population in Western populations. Diabetic neuropathy is a priori the most common and the most common specific complications of diabetes. It can of course touch the lower limbs, the vegetative nervous sy…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
New heart ablation tracker shows promise for AFib patients
Disease control CompletedPulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. A novel technology was recently developed to allow an automatic points annotation when indirect parameters of lesion formation reach predefined target values. The aim of the study was to eval…
Sponsor: Giulio Zucchelli • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Experimental hepatitis b drug shows promise in early trial
Disease control Stopped earlyPatients with chronic HBV infection will receive either ARC-520 alone or ARC-520 in combination with other treatments such as entecavir (ENT) or tenofovir (TDF) and/or pegylated interferon (PEG IFN) alpha 2a therapy, and be evaluated for safety and efficacy.
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New back surgery study shows promise for disc disease patients
Disease control CompletedThe purpose of this study is * to evaluate the effectiveness of MAST techniques for anterior/lateral and posterior approaches in Degenerative Disc Disease (DDD) patients with spondylolisthesis (≥ grade I). * To assess how single or double level MAST(Minimal Access Spinal Technol…
Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Balloon over stent? new study tests Drug-Coated option for heart disease
Disease control CompletedDrug-Coated Balloon (DCB) angioplasty is similar to plain old balloon angioplasty procedurally, but there is an anti-proliferative medication paclitaxel coated on the balloon. Treating in-stent restenosis (ISR) with the DCB has the theoretical advantage of avoiding multiple stent…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Poop pills for kids? new study tests fecal transplants against stubborn gut infections
Disease control By invitation onlyFecal Microbiota Transplant (FMT) in pediatric patients with recurrent C. Difficile with or without Inflammatory Bowel Disease (IBD) The aims of this study are to determine the safety and efficacy of FMT treatment in pediatric patients with recurrent or moderate to severe C. Dif…
Phase 1 • Sponsor: Judith Kelsen • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Mice with human tumors could unlock personalized cancer therapies
Knowledge-focused Recruiting nowBy obtaining clinical specimens from participants with triple negative breast cancer (TNBC), colorectal cancer (CRC), high grade serous ovarian cancer (HGSOC), and other select tumor types to establish and profile as freshly implanted tumors in mice, the aim of this study is to i…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Artificial meniscus shows promise for Post-Surgery knee pain
Disease control CompletedThe NUsurface® Meniscus Implant SUN Clinical Trial is a multi-center, single-arm, prospective, open label, non-randomized, observational clinical trial to gather safety and probable clinical benefit data on the NUsurface® Meniscus Implant in treated the target population.
Sponsor: Phoenix Kinetics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat blood cancer
Disease control OngoingThis research study is evaluating a combination of two drugs, ibrutinib and obinutuzumab, as a possible treatment for Chronic Lymphocytic Leukemia (CLL).
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug combo shows promise for Hard-to-Treat sarcomas
Disease control CompletedAssessment of the efficacy and safety of trabectedin and metronomic cyclophosphamide (CP) in patients with advanced pretreated soft-tissue sarcomas, once the Maximum Tolerated Dose (MTD) have been determined (phase I trial).
Phase 1/2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a lower warfarin dose make aortic valve replacement safer?
Disease control OngoingThe purpose of the proposed study is to assess the occurrence of bleeding, valve-related thromboembolism and valve thrombosis with the On-X Aortic Prosthetic Heart Valve when targeted at an International Normalized Ratio (INR) level of 1.8 (1.5-2.0 range) during a 5-year follow-u…
Sponsor: On-X Life Technologies, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Shocking nerves back to life: new hope for amputees
Symptom relief Recruiting nowThe purpose of this study is to evaluate the effectiveness of providing sensation of the missing limb to individuals with lower limb loss, including above and below knee amputees. The approach involves delivering small electrical currents directly to remaining nerves via implante…
Sponsor: Louis Stokes VA Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
New proton therapy aims to save eyes from removal in large melanoma cases
Disease control Stopped earlyOcular melanomas have been treated for a long time by enucleation, with an unfavorable major impact on the patient's quality of life, social life, self-image, how they feel about others and about living with this disability. As a matter of fact, classical radiation therapy by pho…
Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Sharper radiation boost aims to tackle head and neck cancers that return
Disease control OngoingThis research study seeks to gain new knowledge about the addition of a carefully targeted "boost" dose of radiation as a possible treatment for recurrent or metastatic head or neck cancer. The name of the study intervention involved in this study is stereotactic body radiotherap…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Less invasive staging for endometrial cancer put to the test
Knowledge-focused OngoingThe aim of this trial is to evaluate the sentinel node policy in early stage endometrial carcinomas at intermediate and high risk of recurrence (by comparing the sentinel node policy to current initial staging protocols).
Phase 3 • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New implant could keep dialysis lifelines open longer
Disease control CompletedThe objective of this study is to evaluate efficacy and safety outcomes following use of the Sirolimus-eluting Collagen Implant (SeCI) in subjects undergoing surgical creation of an AV fistula for vascular access (index procedure).
Phase 3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New artificial disc could replace fusion for neck pain
Disease control CompletedThis study is intended to demonstrate that the Simplify® Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) when used to treat one level between C3 to C7 for cervical degenerative disc disease (DDD) defined as intractable radicul…
Sponsor: NuVasive • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC